Trials / Sponsors / LAPIX Therapeutics Inc.
LAPIX Therapeutics Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis Atopic Dermatitis (AD), Psoriasis (PsO) | Phase 1 | 2025-06-15 |
| Recruiting | Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 1 | 2024-12-15 |
| Completed | First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; Autoimmune Diseases, Multiple Sclerosis | Phase 1 | 2023-10-30 |
| Completed | An Observational Biomarker Study in Multiple Sclerosis (MS) Patients Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive | — | 2023-03-28 |